Gene · 9260
Papers4,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions. | Haematologica | 2023 | 38037800 | PubTator, text mining | PubMed |
| Advances and challenges of immunotherapies in NK/T cell lymphomas. | iScience | 2023 | 38026157 | PubTator, text mining | PubMed |
| Single-Cell Profiling of Tumor-Associated Neutrophils in Advanced Non-Small Cell Lung Cancer. | Lung Cancer (Auckl) | 2023 | 38025400 | PubTator, text mining | PubMed |
| Tumor microenvironment in Hodgkin lymphoma: novel prognostic factors for assessing disease evolution. | J Med Life | 2023 | 38024830 | PubTator, text mining | PubMed |
| Characterization of target gene regulation by the two Epstein-Barr virus oncogene LMP1 domains essential for B-cell transformation. | mBio | 2023 | 38009935 | PubTator, text mining | PubMed |
| Cross Sectional Anatomy and Magnetic Resonance Imaging of the Juvenile Atlantic Puffin Head (Aves, Alcidae, Fratercula arctica). | Animals (Basel) | 2023 | 38003052 | PubTator, text mining | PubMed |
| Tough soldering for stretchable electronics by small-molecule modulated interfacial assemblies. | Nat Commun | 2023 | 38001116 | PubTator, text mining | PubMed |
| Perinatal health effects of herbicides exposures in the United States: the Heartland Study, a Midwestern birth cohort study. | BMC Public Health | 2023 | 37993831 | PubTator, text mining | PubMed |
| Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease. | J Transl Med | 2023 | 37990219 | PubTator, text mining | PubMed |
| LMP2 and TAP2 impair tumor growth and metastasis by inhibiting Wnt/β-catenin signaling pathway and EMT in cervical cancer. | BMC Cancer | 2023 | 37986152 | PubTator, text mining | PubMed |
| Role of inositol polyphosphate-4-phosphatase type II in oncogenesis of digestive system tumors. | World J Gastrointest Oncol | 2023 | 37969410 | PubTator, text mining | PubMed |
| The Dual Functions of Andrographolide in the Epstein-Barr Virus-Positive Head-and-Neck Cancer Cells: The Inhibition of Lytic Reactivation of the Epstein-Barr Virus and the Induction of Cell Death. | Int J Mol Sci | 2023 | 37958849 | PubTator, text mining | PubMed |
| Potential Associations between Vascular Biology and Hodgkin's Lymphoma: An Overview. | Cancers (Basel) | 2023 | 37958472 | PubTator, text mining | PubMed |
| Juvenile dermatomyositis: association between nail fold capillary end row loop- area under the curve- and disease damage indicators. | Pediatr Rheumatol Online J | 2023 | 37957619 | PubTator, text mining | PubMed |
| Unique synapomorphies and high diversity in South American Raji-related Epstein-Barr virus genomes. | Mem Inst Oswaldo Cruz | 2023 | 37937604 | PubTator, text mining | PubMed |
| Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect. | J Transl Med | 2023 | 37932756 | PubTator, text mining | PubMed |
| Adult's Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: A case report. | Clin Case Rep | 2023 | 37927984 | PubTator, text mining | PubMed |
| Engineered small extracellular vesicles as a novel platform to suppress human oncovirus-associated cancers. | Infect Agent Cancer | 2023 | 37915098 | PubTator, text mining | PubMed |
| Extracellular Vesicles as a Translational Approach for the Treatment of COVID-19 Disease: An Updated Overview. | Viruses | 2023 | 37896755 | PubTator, text mining | PubMed |
| MicroRNA Expression Profile in Bone Marrow and Lymph Nodes in B-Cell Lymphomas. | Int J Mol Sci | 2023 | 37894763 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9260/papers?page=11